HFMA

06

05

Simplifying the revenue cycle while building resilience

“Several senior financial leaders discuss their organizations’ revenue cycle management (RCM) optimization initiatives, focusing on a variety of strategies, including eligibility checks, denials prevention programs and automation.”

Medicaid eligibility: Strategies to provide care access and maximize reimbursement

Is your hospital or healthcare system constantly seeking ways to help patients access care through Medicaid while maximizing their own reimbursement? Look no more as this sponsored survey unveils effective solutions for these challenges.

Covenant Health sees a 4.6-fold ROI by automating workflows for philanthropic medical financial aid programs

Read about this solution that combines artificial intelligence (AI) with live, human patient advocates to find philanthropic programs, appropriately match and apply those programs to patients and convert uncompensated care to cash.

Thought Leadership Retreat summary reports

Read reports from HFMA's Annual Thought Leadership Retreat.

Revenue Cycle Insights: February 2022

This month's issue leads off with the news that the federal government is taking a look at provider billing in the COVID era through audits by the Office of Inspector General.

Cost-Reduction Strategies Boost, Sustain Recovery

Persistent pandemic conditions are forcing hospitals and health systems to stretch their thinking as they set strategic goals. They are adjusting to managing fluctuating levels of care along with addressing shifts in payer mix, consumers’ demands and increasing cost pressures. These changes, combined with the challenge of inconsistent patient volumes, is putting unprecedented financial pressures…

Optimizing the revenue cycle by streamlining and automating payment collections

Nine healthcare finance professionals dive into strategies to help entities evolve to meet challenges faced by providers and payers in finding qualified employees in today’s workforce.

Cost Effectiveness of Health Report, December 2021

The December HFMA’s Cost Effectiveness of Health Report, sponsored by Kaufman Hall, leads off with the fourth and final report for 2021 in HFMA’s Healthcare 2030 series, focused on the long-term direction of strategic investment for hospitals and health systems. Also included are an article describing a new “employer-friendly” model of center of excellence and a commentary on how the FDA’s accelerated approval process may unintentionally be increasing the nation’s drug expense.